---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-036453"
form_type: "8-K"
ticker: "ZVSA"
cik: "0001859007"
company_name: "ZyVersa Therapeutics, Inc."
filed_at: "2024-09-16T23:59:59+00:00"
generated_at: "2026-05-31T04:42:30.621441+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Zyversa Therapeutics enters $1.4M ATM equity offering with A.G.P.

## Summary
- Entered ATM Agreement with A.G.P./Alliance Global Partners to sell up to $1,397,396 of common stock.
- Agent receives 3.0% commission; sales at prevailing market prices under effective shelf registration.
- Proceeds to be used for working capital and general corporate purposes, including R&D.
- No minimum offering; Company not obligated to sell any shares under the Agreement.

## SEC filing metadata
- accession: 0001493152-24-036453
- form_type: 8-K
- ticker: ZVSA
- cik: 0001859007
- company_name: ZyVersa Therapeutics, Inc.
- filed_at: 2024-09-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.0, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1859007/000149315224036453/0001493152-24-036453-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1859007/000149315224036453/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-036453
- JSON: https://secwatch.observer/filing/0001493152-24-036453.json
- Plain text: https://secwatch.observer/filing/0001493152-24-036453.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.